These data suggest that EPO may directly activate the PI3K/Akt pathway and overcome the HFD-induced impairment in the insulin-related signaling, leading to the improvement of glucose intolerance in the livers of HFD-fed mice. This evidence concerns the gene EPO and Glucose intolerance.